Key facts
- This page summarizes Alexander V Lazarev's Form 4 filing for PRESSURE BIOSCIENCES INC.
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 30 Sep 2024, 16:05.
Alexander V Lazarev - 27 Sep 2024 Form 4 Insider Report for PRESSURE BIOSCIENCES INC
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 27 Sep 2024
- Net transaction value
- +$528
- SEC form
- 4
- Accepted by SEC
- 30 Sep 2024, 16:05:18 UTC
- Prior SEC filing
- 28 Mar 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Alexander V. Lazarev
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Alexander V Lazarev filed Form 4 for PRESSURE BIOSCIENCES INC on 30 Sep 2024.
Change
- Previous filing in this sequence was filed on 28 Mar 2024.
- Current net transaction value: +$528.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PBIO
transaction
COMMON STOCK
Other
- Transaction value
- $528
- Shares
- +18,863
- Change %
- +102%
- Price
- $0.0280
- Shares after
- 37,400
- Date
- 27 Sep 2024
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Interest on convertible preferred stock paid in shares of common stock.